Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

JNJ-7706621

SKU: orb1225037

Description

A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM), and no activity for Plk1 or Wee1; arrests the cell cycle at the G2-M phase; shows significant antitumor activity in tumor xenograft model.

Images & Validation

Key Properties

CAS Number443797-96-4
MW394.356
Purity>98% (HPLC)
FormulaC15H12F2N6O3S
SMILESO=S(C1=CC=C(NC2=NN(C(C3=C(F)C=CC=C3F)=O)C(N)=N2)C=C1)(N)=O
TargetCDK
Solubility10 mM in DMSO

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

JNJ7706621 | JNJ 7706621

Similar Products

  • JNJ-7706621 [orb1301051]

    99.85% (May vary between batches)

    443797-96-4

    394.36

    C15H12F2N6O3S

    5 mg, 10 mg, 25 mg, 50 mg, 1 mg, 100 mg, 1 ml x 10 mM (in DMSO), 200 mg
  • 3-Methylthienyl-carbonyl-JNJ-7706621 [orb1984475]

    443798-09-2

    378.43

    C14H14N6O3S2

    100 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

2 mg
$ 110.00
5 mg
$ 180.00
10 mg
$ 310.00
25 mg
$ 480.00
50 mg
$ 850.00
100 mg
$ 1,190.00
500 mg
$ 2,380.00